Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

The company is also seeking global pharmaceutical partners for further codevelopment of hzVSF for HBV and an ... producing such test kits, and has already brought to market rapid diagnostic ...

Results are seen within 15 minutes. ...the rapid test provides early detection of acute kidney injury... RenaStick was evaluated in animal models of acute kidney injury and in humans. The ...

In collaboration with Lion TCR Pte Ltd, the test has been deployed in a Hepatitis B virus-TCR T-cell therapy clinical trial, called the SAFE-T-HBV trial ... T Tan et al, A rapid method to assess ...